World EPA Congress 2022 | Terrapinn | 21 March 2022 | Beurs van Berlage, Damrak 243, 1012 ZJ Amsterdam, Netherlands

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 250 speakers, multiple streams and over 1000 attendees from pharma, biotech and Payers/HTA’s.

2022 Speakers

David Alderson
Director, Cogentia Healthcare Consulting

Ana Filipa Alexandre
Global Director, Health Economics Outcomes Research, Astellas Pharma

Ines Alves
President, ANDO Portugal

Luigi Angelillo
Associate Director, HEOR & New Products Market Access (EMEA)

Glenn Anley
Global Director Pricing & Access, Covid Therapeutics, GSK

Ad Antonisse | Director Market Access & External Affairs, AstraZeneca BV

Marnix Artz
Head of Patient Access, Pricing & Public Affairs, Netherlands | Merck Group

Cecilie Astrup
Health Economist, Amgros I/S

Nico Bacharidis
Founder, growpal

Alex Bastian
VP Value & Market Access, A.M. Pharma

Shawn Bates
Vice President Global Portfolio Leader, Certara

Tomer Ben Zaken
Regional Business Operation Lead, Takeda

Jesper Bjerggren
European Market Access Lead Respiratory/Digital Health, Teva Pharmaceuticals

Axel Boehnke
Director Market Access EU North, PTC Therapeutics

Amanda Bok
CEO, European Haemophilia Consortium

George Boretos
Co-Founder & Co-CEO, Cube RM

Pedro Borga
Senior Consultant, Valid Insight

Vidya Breeveld
Founder, Transmineo

Alberto Briones
Senior Consultant, Lifescience Dynamics

Anna Bucsics
Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

David Carr
Director, Global Pricing and Market Access, PRECISIONadvisors

Sandro Cesaro-Tadic
Head of Market Access & Innovative Value Strategies, Oncology Europe, AstraZeneca

Sandro Cesaro-Tadic
Head of Market Access & Innovative Value Strategies, Oncology Europe

José Luis Sánchez Chorro
Market Access Director Spain and Portugal, Jazz Pharmaceuticals

Ali Ciger
Vaccines Country Lead, Pfizer

Warren Cowell
Director Market Access UK, Shionogi Ltd

Mike Crosher
Managing Director, Chugai Pharma UK

Charles-Etienne de Cidrac
Director Of Health Insurance, AXA

Erwin De Cock
Exec. Director, Real World and Late Phase, Syneos Health

Marijke de Vries
Deputy Secretary, Scientific Advisory Council (Medicines Committee), Zorginstituut

Filippo Drago
Full Professor of Clinical Pharmacology, University of Catania

Dominik Dziurda, Head Of Health Services Division, AOTMiT

Emma Eatwell
Deputy Managing Director, International Policy and Market Access, Hanover Communications

Ahmed Edathodu
Director, Access Infinity Ltd

Shane Elder
Global Pricing Director, Astrazeneca

Osama Elzayet
Market Access Director, Levant & Egypt (Levant-E), Abbvie

Michael Ermisch
Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Gina Ewy
Head of Global Market Access, Hansa Biopharma

Pascaline Faivre
Senior Director Market Access EU, Certara

Stefaan Fiers
Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda

Benjamin Gannon
Head of Int’l Access & Policy, Guardant Health

Philippe Ghyssels
VP Corporate and Global Public Affairs, Ipsen

Ramiro Gilardino
Head of Global Value, Access & Pricing, Lumen Value & Access

Christoph Glatzer
Chief Global Value and Access Officer, Johnson & Johnson

Josie Godfrey
Co-Founder and CEO, Realise Advocacy

Sylvie Greneche
Global Head of Market Access, General Medicines, Sanofi

Marcus Guardian
Chief Operating Officer, EUnetHTA

Laura Guarga
Consultant of Pharmacoeconomic Department, CatSalut

Josep Maria Guiu Segura
Head of Pharmacy, Pharmacy and Medicines Area, Consorci De Salut I Social De Catalunya

Clare Hague
Therapy Area Market Access Lead, Hematology, Janssen Pharmaceuticals

Tanja Heidbrede
Head RWE Central EU, UCB

Birgit Holz
Global Head of Contracting Innovation, Sanofi

Bill Hu
Professor of Finance, Arkansas State University

Giorgio Iotti
Head Of Program Leadership And Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Dawn Ireland
President, CDH International

Ulrike Jacobi
Head Of External Affairs And Market Access, Amgen

Saira Jan
Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey

Christel Jansen
Principal Consultant, Vintura

Elizabeth Johnson
Co-founder, National Association of Medication Access & Patient Advocacy

Rosemary Jose
Senior Director, Strategic Market Access, Open health

Navin Joshi
Head of Pricing & Market Access, GlaxoSmithKline

Lisette Kaskens
Senior Global Market Access Manager, Advanced Accelerator applications

Alison Keetley
Head of Market Access South East Asia, Johnson & Johnson

Jeanne Kern
Sr Consultant, Lumen Value & Access

Sigrid Klaar
Medical advisor, The Dental and Pharmaceutical Benefits Agency T.L.V.

Jelle Kleijn
Global Head of Acanthamoeba Keratitis, SIFI

Charles Klippel
Professor of Practice, NYU School of Law

Tomasz Kluszczynski
Partner- Value, Access and Policy, Vintura

Jolanda Koenders
Head Of Patient Value And Access, Takeda

Diane Langenbacher
Partner, Kautz5 gUG

GAEL LE ROUZO
Global Market Access Director, Eusa Pharma

Jost Leemhuis
Head Of Safety Science, Roche

Giovanny Leon
Pricing & Access Regional Director - LatAm & Canada, Novartis AG

Herve Lilliu
CEO, Inbeeo

Sune Lindgaard
Head of Business Intelligence and Health Economy, Amgros I/S

Sara Lopes
Senior Director, Global Market Access & Pricing Governance, Shionogi BV

Elena Lungu
Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada

Richard Macaulay
Vice President, Global Pricing and Market Access, PRECISIONadvisors

Joerg Mahlich
Market Access and Government Affairs Lead, Miltenyi Biomedicine GmbH

Andrea Mantovani
Vice President, Global Market Access, Alira Health

Marco Marchetti
Director of Health Technology Assessment Unit, National Agency for Regional Care Services, Agenzia Nazionale per i Servizi Sanitari Regionali- Agenas

Nick Melling
Senior Director, Market Access Europe, Fingerpost Consulting

Vanessa Mirsky
Senior Director, Ex-Us Strategic Payer Partnerships, EQRx, Inc.

Paolo Morgese
EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

Frederik Mortensen
Head of Market Access, Novartis Oncology Netherlands, Novartis

Lisa Mostovoy
VP, Payer Partnerships, EQRx, Inc.

Michael Muller
Head Of Market Access, Western Europe, Sun Pharma

Elvira Müller
Vice President, Certara Evidence & Access (EvA), Certara

Jack Mycka
Vice President, PRMA & Emerging Biotech Commercialization, Indegene

Alexander Natz
Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Claudia Neuber
Head of Global Pricing, Astrazeneca

Declan Noone
President, European Haemophilia Consortium

Susan Oliveria
Chief Scientific Officer, Genesis Research LCC

Melvin Olson
Global Head IE Strategy and Innovation, Novartis

Jennifer O'neill
Director, Medical Affairs, Merck

Mario Ouwens
Group Director Medical & Payer Evidence Statistics, AstraZeneca

Elena Panitti
Global Head Real World Evidence Excellence, Novartis

Julien Patris
Director Market Access & Policy – Europe / Canada / MEA (CEMEA), Alnylam

Marco Penske
Head Of Market Access And Health Care Affairs, Boehringer-ingelheim

Diogo Teixeira Pereira
Policy Analyst - Office for International Relations and Development, Infarmed

Elena Perez Lopez
Engagement Manager, Lifescience Dynamics Ltd

Ed Pezalla
Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company

Christian Pichardo
Senior Health Economics Consultant, Certara

Lara Pippo
Head Of Market Access, Italy, CSL Behring

Ashley Pitcher
EMEA Lead for Artificial Intelligence and Real World Evidence, IQVIA

Ana Plata
Head of Global Pricing Implementation BBU, AstraZeneca

Mary Lynne Van Poelgeest-Pomfret
President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Jenniffer Prescott
Programme Director - Process and Operations, NICE

Rafaat Rahmani
Founder and Chief Executive Officer, Lifescience Dynamics Ltd

Sreeram Ramagopalan
Global Head Real-World Evidence (Market Access), Roche

Andrea Rappagliosi
Vice President Market Access, Public Affairs & Communication EMEA, Canada and LATAM, Edwards Lifesciences

Marco Rauland
Vice President Global Market Access & Pricing - Strategic Planning, Merck Group

Vijay Reddy
Senior Director - Global Market Access Strategy - Biologics, Biocon Biologics

Isabell Remus
Head Biopharma & Specialty Business Europe, Sandoz

Trevor Richter
Director Access and Reimbursement, Canada, Gilead Sciences

Andre Roeder
Head Global Market Access, TETEC AG

Igor Rudychev
Vice President, Enterprise Analytics, Horizon Therapeutics

Alric Ruether
Head, International Affairs, IQWiG

Sandrine Ruiz
Director Global Market Access and Pricing, Independent Sandrine

Claus Runge
Global Head of Market Access, Public Affairs & Sustainability, Bayer

Marika Russo
Market Access Director, Region Europe, Novartis

Rachele Saccon
Engagement Manager, Lifescience Dynamics Ltd

Gustavo Saraiva Dos Anjos
Global Payer Strategy Director, Biologics, GlaxoSmithKline

Sophie Schmitz
Managing Partner, Partners4Access

Michael Schroter
Co-Head Sustainable Healthcare Equity, HSBC

Michael Seewald
VP, Global Evidence, Medical BioPharmaceuticals, AstraZeneca

Ayman Semaan
Head of Market Access, BIOLOGIX

Raja Shankar
Managing Principal and Innovation Lead, IQVIA

Rita Shorjian
Associate Commercial Director, Eastern Europe Middle East and Africa, Rinvoq - AD, AbbVie

Sanja Stanisic
Associate Director, Certara Evidence & Access, Certara

Oliver Staples
Principal - IQVIA Patient, Value & Access Strategy Consulting, IQVIA

Pernille Storm
Head of Global Pricing, H. Lundbeck A/S

Monika Szkultecka-Debek
Vice President, Qualitas Vitae Institute Foundation

Giovanni Tafuri
Director International Market Access and Policy, Apellis Pharmaceuticals

Chris Teale
Senior VP Market Access, Ipsos MORI UK Ltd

Jörg Tomeczkowski
Associate Director, Global HTA Decision Support, Janssen

Andreas Uttenweiler
Head Patient Value Access & Public Affairs, Takeda Pharma AG

Inneke Van De Vijver
Strategic Advisor - Reimbursement Pharmaceuticals, R.I.Z.I.V. I.N.A.M.I. National Health Insurance Agency

Bart Van Den Daele
Head of External Affairs – Director Market Access - Belux, Gilead Sciences

Goedele Van Haasteren
Staff Member, Swiss Federal Office of Public Health

Sahar Barjesteh van Waalwijk van Doorn-Khosrovani
Medical Advisor, CZ

Lavni Varyani
Founder, Pharma BP DMCC

Kärt Veliste
Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia

Anne Willemsen
Senior Project Manager, Zorginstituut Nederland / EUnetHTA

May Yaker
Market Access & Policy Expert, Alnylam

Natasa Zibelnik
Global Head of Value, Access and Pricing, Eusa Pharma

Peter Zimmermann
Sr. Director, Services Sales, Model N

Zinajda Zolic-Karlsson
Senior Advisor HTA and Reimbursement, Norwegian Medicines Agency

Fabrizio Zucca
Director Market Access DACH, Alnylam Pharmaceuticals

2022 Sponsors

PLATINUM SPONSORS:
• Certara
• Lifescience Dynamics Ltd

SILVER SPONSORS:
• Cube RM
• Partners4Access
• Valid Insight
• Access Infinity Ltd
• Genesis Research Inc
• Inbeeo
• Indegene
• Ipsos MORI UK Ltd
• OPEN Health
• Model N
• Pharma BP DMCC
• Precision Value & Health
• Syneos Health

GOLD SPONSORS:
• Healthcare Consultancy Group
• IQVIA

BRONZE SPONSORS:
• Alira Health
• Cogentia Healthcare Consulting
• Fingerpost Consulting
• Vintura